Tag: genomics
-
Institute, Company Studying Neuro Disease Proteins
The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments.
-
Synthetic Bio Company Starts Up, Raises $53 Million
A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round.
-
Protein Engineered to Boost Nerve Cell Imaging
Engineers and neuroscientists developed a synthetic protein that illuminates electrical activity in animal brain nerve cells, with a process using robotics to test millions of protein candidates in cells.
-
Quick, Portable Soil Pathogen Test Process Developed
A university plant science lab developed techniques with readily-available components and materials that make detecting destructive microbes in farm soil faster and easier.
-
RNA Vaccine Shows Promise with Infant Viral Diseases
A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients.
-
Gut Tissue From Stem Cells Simulated on Organ Chips
Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients.
-
Cancer Analytics Company Acquired in $1.9B Deal
The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.
-
Engineered Virus Shows Promise in Some Brain Tumors
A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success.
-
Report: 19 New Precision Medicines Approved in 2017
A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals.